Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma--final evaluation. E.O.R.T.C. Brain Tumor Group.
D001932:Brain Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002986:Clinical Trials as Topic; D005260:Female; D005910:Glioma / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use*; D008297:Male; D009364:Neoplasm Recurrence, Local; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D011379:Prognosis; D011897:Random Allocation; D012075:Remission, Spontaneous; D013997:Time Factors
D009607:Nitrosourea Compounds; D008130:Lomustine